WITHDRAWN: India's Path to Cervical Cancer Control: From Obstacles to Opportunities in HPV Vaccine Uptake.

IF 3.4 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Public Health Research & Practice Pub Date : 2026-01-20 DOI:10.1071/PU25036

Jubina Balan Venghateri, Priyansh Nathani, Jasleen Kaur, Anita Gadgil

引用次数: 0

Abstract

Ahead of Print article withdrawn by publisher.

查看原文本刊更多论文

印度的子宫颈癌控制之路：从HPV疫苗摄取的障碍到机遇。

背景：宫颈癌是一项重大的全球公共卫生挑战，在低收入和中等收入国家（LMICs）造成的负担高得惊人，约88%的死亡发生在这些国家。单一的，确定的因素，导致侵袭性宫颈癌是一种致癌类型的人乳头瘤病毒（HPV）感染。如果在早期和侵袭前阶段发现宫颈癌，那么宫颈癌是高度可预防和高度可治疗的。几乎所有的子宫颈癌病例都可以通过接种HPV疫苗来避免。目的：在这篇前瞻性文章中，我们追踪了印度在HPV免疫规划方面的努力，以进行初级预防，补充早期发现和筛查规划。此外，我们还讨论了可能干扰这一使命的障碍，并强调了将为更好地了解如何消除宫颈癌铺平道路的资产。方法：这篇观点文章利用世界卫生组织的有效卫生系统框架的构建模块来检查印度目前的HPV免疫接种工作。该框架与同行评议研究和相关灰色文献的见解相结合，以确定影响HPV疫苗接种规划实施的关键促进因素和障碍。结果：全球可获得和批准的HPV疫苗虽然成功，但在中低收入国家仍然昂贵。因此，印度一直在努力研制本地生产的HPV疫苗。这种疫苗的可负担性使其影响可能具有变革性，但其未来的成功取决于扩大规模并利用有效战略在全国范围内实施。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Public Health Research & Practice PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-

CiteScore

6.70

自引率

0.00%

发文量

审稿时长

20 weeks

期刊介绍： Public Health Research & Practice is an open-access, quarterly, online journal with a strong focus on the connection between research, policy and practice. It publishes innovative, high-quality papers that inform public health policy and practice, paying particular attention to innovations, data and perspectives from policy and practice. The journal is published by the Sax Institute, a national leader in promoting the use of research evidence in health policy. Formerly known as The NSW Public Health Bulletin, the journal has a long history. It was published by the NSW Ministry of Health for nearly a quarter of a century. Responsibility for its publication transferred to the Sax Institute in 2014, and the journal receives guidance from an expert editorial board.